Tag Archives: Celgene

Abraxane Approved For Treatment of Pancreatic Cancer

The FDA recently approved Abraxane for the treatment of metastatic pancreatic cancer. This is a breakthrough for Celgene (who acquired the drug with their acquisition of Abraxis), and is the first significant change in the treatment of pancreatic cancer in … Continue reading

Posted in pancreatic cancer | Tagged , | Leave a comment

Latest Pancreatic Cancer Articles

During the recent ASCO GI conference, the big news was the release of the results of the Abraxane trials.  The data show that the lives of pancreatic cancer patients can be extended by two months when adding Abraxane into the … Continue reading

Posted in Drug Development, pancreatic cancer | Tagged , , , , | Leave a comment